貨號：GS40162

Dalnicastobart is a humanized, agonistic monoclonal antibody designed as an immunotherapy targeting the B-cell surface antigen CD40. It functions by stimulating the CD40 signaling pathway, leading to potent activation of antigen-presenting cells, enhancement of T-cell-mediated immune responses, and direct anti-tumor effects against CD40-expressing malignancies. This immunostimulatory and antineoplastic agent is being investigated for the treatment of various cancers, either as a monotherapy or in combination with other immunotherapeutic or chemotherapeutic regimens.